GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Huons Co 243070.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

15,690

-2.43%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Huons Co

Its shares trade on KOSDAQ under the ticker 243070.KQ. It has been listed since 3 June 2016. In the fiscal year to 31 December 2025, it reported revenue of ₩620.77bn and net income of ₩42.66bn. At that date it held total assets of ₩680.28bn and shareholders' equity of ₩373.91bn.

Huons Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2016-06-03.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
3 Jun 2016
Website
huons.com ↗

Leadership

Pay as last reported

  • Su Yeong SongChief Executive Officer, Director, since 2022
  • Mr. Seong Tae YoonVice Chairman, Other Non-Executive Director
  • Mr. Jae Cheon GohManaging Director
  • Mr. Jin Seok LeeManaging Director
  • Mr. Yin Seop KimManaging Director
  • Mr. Seong Cheon ChoAssistant Managing Director
  • Mr. Ho Sun JungAssistant Managing Director
  • Mr. Gyo Pil KimInternal Auditor
  • Mr. Si Baek KimAssistant Managing Director
  • Mr. Jae Hun LeeAssistant Managing Director
  • Mr. Jun Gyo OhAssistant Managing Director
  • Mr. Won Gil ParkAssistant Managing Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Huons Co Ltd manufactures pharmaceutical products in Seongnam, South Korea.
  • The company's IPO in 2016 established a strong market presence in the Health Care sector.
  • Huons Co Ltd focuses on pharmaceutical manufacturing within the Korean market.

Weaknesses

  • Huons Co Ltd operates primarily in the domestic South Korean market without international expansion.
  • The company's business is limited to pharmaceutical manufacturing without diversification.
  • Huons Co Ltd has no mention of international partnerships or global distribution networks.

Opportunities

  • The growing South Korean pharmaceutical market offers expansion potential for Huons Co Ltd.
  • Increasing demand for healthcare products in Asia presents new market opportunities.
  • Huons Co Ltd can leverage its IPO success to enter new product segments.

Threats

  • Competition from established global pharmaceutical companies in South Korea.
  • Regulatory changes in the Korean pharmaceutical industry could impact operations.
  • Economic downturns in South Korea may reduce healthcare spending.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.